Thermo Fisher Scientific launches Detachable Dynabeads to enhance cell therapy development and production
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing
T cell isolation and controlled release delivers flexibility and control in process development, clinical trials and commercial manufacturing
A nucleic acid delivery solution to advance life science research and genetic medicines
High-performance liquid chromatography (HPLC) stands as one of the foremost analytical techniques in use today. Its operational principle involves the separation of compounds according to their polarity. Unlike traditional liquid chromatography (LC), HPLC uses elevated pressure to propel the solvent through the column, significantly expediting separations while minimizing solvent usage.
Explore guidelines and recommendations for the design and generation of DNA constructs to generate a recombinant protein with the Cytiva Protein Select resin
The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level
A case study comparing process development for the purification of recombinant proteins using Cytiva Protein Select resin vs a nonaffinity method
Expert roundtable forum discussion to explore the value of high-sensitivity immunoassays
Tropical Fever Panel a syndromic PCR test, targets the causes of tropical fever infections
New frontiers in glioblastoma: Patient-derived organoids on Axion BioSystems’ Maestro Z impedance-based live-cell analysis system offer new insights into CAR T bioactivity and immunotherapy efficacy
A study suggests a new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer
The study was commissioned and funded by the National Institute for Health and Care Research (NIHR), and its leading partners were The University of Manchester, Northern Care Alliance NHS Foundation Trust and Warwick Medical School’s Clinical Trials Unit, who specialize in research in emergency and critical care